Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
European Heart Journal|July 24, 2020
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptomJemma C Hopewell, Alison Offer, Richard Haynes, et al.
Circulation. Genomic and Precision Medicine|February 17, 2018
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE StudySarah Parish, Jemma C Hopewell, Michael R Hill, et al.
Clinical Kidney Journal|December 8, 2018
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY studyWilliam G Herrington, David Preiss, Richard Haynes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 23, 2016
Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine RatioWilliam Herrington, Nicola Illingworth, Natalie Staplin, et al.
Clinical Kidney Journal|September 9, 2020
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY studyWilliam G Herrington, David Preiss, Richard Haynes, et al.
Kidney International|February 4, 2018
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapyBenjamin C Storey, Natalie Staplin, Charlie H Harper, et al.
Journal of Physical Activity & Health|January 22, 2026
Generating Older Active Lives Digitally (GOALD): Exploring Older Adults' Views of Digital Technology for Physical ActivitySimone A Tomaz, Colin B Shore, Gemma C Ryde, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 2015
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)Borislava Mihaylova, Iryna Schlackow, William Herrington, et al.
JAMA Ophthalmology|July 10, 2020
Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical TrialTimothy L Jackson, Cristina Soare, Caroline Petrarca, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 31, 2023
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization StudyKillian Donovan, William G Herrington, Guillaume Paré, et al.
Pageof 13